Claire Poll is CLO at Verona Pharma plc (VRNA). They have made 2 open-market trades across 1 company since 2022, most recently 2024-02-01.
CIK 0001836820
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 2 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| VRNA | 1,623,487 | $173.6M |
Shares reported on the most recent Form 4, priced at the 2024-02-05 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| VRNA | SELL · 10b5-1 | 2023-08-03 | 2023-08-07 | $2.52 | $174K | -7.2% | +1.1% | -20.7% |
| VRNA | SELL · 10b5-1 | 2023-08-01 | 2023-08-03 | $2.64 | $83K | -10.0% | -3.4% | -29.3% |
| VRNA | SELL · 10b5-1 | 2023-05-01 | 2023-05-03 | $2.58 | $415K | -0.5% | +2.1% | +2.0% |
| VRNA | SELL | 2023-02-01 | 2023-02-03 | $2.59 | $394K | +2.4% | +5.5% | -1.9% |
| VRNA | SELL | 2022-12-22 | 2022-12-27 | $2.69 | $646K | +0.8% | -4.5% | -14.6% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.